from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1530/adh

LFCtreatmentdescriptionclass of inhibitor

-0.888

Amikacinug/mL Amikacintranslation

-0.120

Cap5-10ug/mL Capreomycintranslation

-0.227

Rox10-50 ug/mL Roxithromycintranslation

-0.418

SM2-5 ug/mL Streptomycintranslation

-1.229

Tet5-10 ug/mL Tetracyclinetranslation

0.808

Rif0.2-5ug/mL Rifampicintranscription

0.130

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.752

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.342

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.208

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.103

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.991

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.989

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.252

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.346

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.280

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.053

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.021

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.391

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.662

KCN5-20 ug/mL Potassium cyaniderespiration

-0.747

NaN30.2-2 mM Sodium aziderespiration

-0.345

Nigericin50 uM Nigericinrespiration

0.576

TRC10-150 ug/mL Triclosanrespiration

2.076

TRZ10-25 ug/mL Thioridazinerespiration

-0.787

Valinomycin0.5-10 uM Valinomycinrespiration

-0.371

ZnSO42 mM ZnSO4respiration

1.020

menadione6-10 ug/mL Menadionerespiration

-0.180

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.210

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.162

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.310

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.735

NRP_1Non-replicating persistence stage 1dosRassociated

-0.321

Amp0.2mg/mL AmpicillincellWall

-0.327

Cephalexin20-100 ug/mL CephalexincellWall

-1.153

Cerulenin0.32-5 ug/mL CerulenincellWall

0.132

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.239

EMB10-20 ug/mL EthambutolcellWall

-1.110

Eta12-40 ug/mL EthionamidecellWall

-2.016

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.723

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.339

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.532

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.054

BZA0.12 mg/mL BenzamidearomaticAmides

0.856

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.424

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.508

H2O24 mM hydrogen peroxideDNAdamaging

-0.353

Levo10 ug/mL LevofloxacinDNAdamaging

0.075

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.341

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.367

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.153

UVUV-irradiationDNAdamaging

0.625

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.546

Antimycin12.5-50 ug/mL Antimycin A?

-0.955

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.333

PA_110-50 ug/mL Antitubercular compound PA-1?

0.321

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.380

PA8240.2-2 ug/mL PA-824?

0.047

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.097

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.792

Verapamil50 uM Verapamil?

0.529

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.283

methoxatin10-20 ug/mL Methoxatin?